ORAL SUSTAINED RELEASE FORMULATION OF TEDISAMIL WITH GASTRIC RETENTION PROPERTIES

摘要

The present invention relates to a novel sustained release formulation with gastric retention properties comprising tedisamil or a pharmaceutically acceptable salt thereof and the use of this formulation in the prevention and treatment of atrial fibrillation, atrial flutter and cardiac ischemia.